We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.14B
AUM Growth
+$78M
Cap. Flow
+$4.03M
Cap. Flow %
0.35%
Top 10 Hldgs %
49.37%
Holding
304
New
70
Increased
124
Reduced
70
Closed
7

Top Buys

Rank Stock Value
1
AVUV icon
Avantis US Small Cap Value ETF
AVUV
+$3.94M
2
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$3.93M
3
NMRA icon
Neumora Therapeutics
NMRA
+$3.31M
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$2.97M
5
MSFT icon
Microsoft
MSFT
+$2.45M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$16M
2
SCHB icon
Schwab US Broad Market ETF
SCHB
+$5.85M
3
JMST icon
JPMorgan Ultra-Short Municipal Income ETF
JMST
+$3.04M
4
SCHF icon
Schwab International Equity ETF
SCHF
+$2.44M
5
EW icon
Edwards Lifesciences
EW
+$2.12M

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.4%
2 Technology 5.18%
3 Healthcare 2.32%
4 Financials 1.59%
5 Consumer Discretionary 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
USBC
251
USBC Inc
USBC
$165M
$233K 0.02%
9,250
– –
IYW icon
252
iShares US Technology ETF
IYW
$25.3B
$231K 0.02%
1,714
– –
STM icon
253
STMicroelectronics
STM
$44B
$231K 0.02%
+5,337
New +$241K
EQ icon
254
Equillium
EQ
$152M
$230K 0.02%
99,688
– –
CRDF icon
255
Cardiff Oncology
CRDF
$73.1M
$228K 0.02%
42,747
+11,600
+37% +$30.8K
IJR icon
256
iShares Core S&P Small-Cap ETF
IJR
$110B
$228K 0.02%
2,064
– –
VZ icon
257
Verizon
VZ
$208B
$227K 0.02%
+5,403
New +$218K
SCZ icon
258
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.3B
$223K 0.02%
3,524
– –
IWF icon
259
iShares Russell 1000 Growth ETF
IWF
$126B
$220K 0.02%
+2,608
New +$210K
TRV icon
260
Travelers Companies
TRV
$77.2B
$217K 0.02%
+944
New +$202K
SPEM icon
261
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.8B
$217K 0.02%
6,000
-1,512
-20% -$53.2K
ILMN icon
262
Illumina
ILMN
$32.6B
$216K 0.02%
1,617
-181
-10% -$24.3K
DUK icon
263
Duke Energy
DUK
$93.8B
$216K 0.02%
+2,233
New +$212K
CCEP icon
264
Coca-Cola Europacific Partners
CCEP
$48.2B
$214K 0.02%
+3,063
New +$210K
BN icon
265
Brookfield
BN
$92.3B
$214K 0.02%
+7,674
New +$207K
BLK icon
266
Blackrock
BLK
$180B
$214K 0.02%
+257
New +$206K
CVS icon
267
CVS Health
CVS
$119B
$214K 0.02%
+2,681
New +$205K
KR icon
268
Kroger
KR
$35.4B
$213K 0.02%
+3,737
New +$184K
LHX icon
269
L3Harris
LHX
$48.9B
$212K 0.02%
+993
New +$209K
MU icon
270
Micron Technology
MU
$1.05T
$209K 0.02%
+1,770
New +$160K
HALO icon
271
Halozyme
HALO
$12B
$209K 0.02%
+5,128
New +$192K
TJX icon
272
TJX Companies
TJX
$149B
$207K 0.02%
+2,038
New +$198K
BSX icon
273
Boston Scientific
BSX
$67.9B
$206K 0.02%
+3,011
New +$194K
MDT icon
274
Medtronic
MDT
$117B
$205K 0.02%
+2,349
New +$200K
GM icon
275
General Motors
GM
$75.7B
$204K 0.02%
+4,508
New +$175K
9 10
11
12 13

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Callan Capital held 304 positions worth $1.14B, up 7.4% from $1.06B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Callan Capital's Q1 2024 filing shows 70 new, 124 increased, 70 reduced and 7 closed positions. Its largest new stake was Neumora Therapeutics: 204,987 shares worth $2.82M. The largest sale was NVIDIA, an estimated $16M.

By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 88% a quarter earlier, followed by Technology and Healthcare.

  • Callan Capital's largest Q1 2024 buy was Neumora Therapeutics: 204,987 shares worth $2.82M.
  • Callan Capital added most to Avantis US Small Cap Value ETF in Q1 2024, an estimated $3.94M increase.
  • Callan Capital's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $16M.
  • Callan Capital fully exited Edwards Lifesciences in Q1 2024, selling an estimated $2.12M.
  • Callan Capital's ten largest holdings make up 49% of its $1.14B portfolio in Q1 2024.
  • Callan Capital opened 70 new positions and closed 7 in Q1 2024.
  • Callan Capital's portfolio value rose 7.4% quarter-over-quarter to $1.14B.

Based on Callan Capital's 13F filing for Q1 2024, filed 3 May 2024.